InvestSMART

Anatara Lifesciences Ltd (ASX: ANR) - Announcements

- Current share price for ANR : $0.009

ASX company news and announcements for Anatara Lifesciences Ltd (ANR) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Anatara Lifesciences Ltd (ANR) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Anatara Lifesciences Ltd (ANR), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Anatara Lifesciences Ltd (ANR)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$3 Application for quotation of securities - ANR 10 Dec 2021 11:11AM $0.145 $0.009 fallen by 93.79%
$3 Anatara Strengthens the Team with New Appointments 6 Dec 2021 9:08AM $0.145 $0.009 fallen by 93.79%
$3 Results of Meeting 16 Nov 2021 1:14PM $0.150 $0.009 fallen by 94%
$3 AGM CEO Presentation 16 Nov 2021 10:47AM $0.145 $0.009 fallen by 93.79%
$3 Chairman's Address to Shareholders 16 Nov 2021 10:45AM $0.145 $0.009 fallen by 93.79%
$3 Appendix 2A 4 Nov 2021 5:58PM $0.140 $0.009 fallen by 93.57%
$3 Appendix 4C & Q1 FY22 Activities Report 29 Oct 2021 5:05PM $0.145 $0.009 fallen by 93.79%
$3 Notification regarding unquoted securities - ANR 27 Oct 2021 12:30PM $0.145 $0.009 fallen by 93.79%
$3 Notification of cessation of securities - ANR 21 Oct 2021 12:14PM $0.145 $0.009 fallen by 93.79%
$3 Notification of cessation of securities - ANR 21 Oct 2021 12:11PM $0.145 $0.009 fallen by 93.79%
$3 Appendix 4G and Corporate Governance Statement 19 Oct 2021 9:06AM $0.140 $0.009 fallen by 93.57%
$3 Annual Report to shareholders 15 Oct 2021 5:44PM $0.145 $0.009 fallen by 93.79%
$3 Notice of Annual General Meeting/Proxy Form 15 Oct 2021 5:43PM $0.145 $0.009 fallen by 93.79%
$3 Annual General Meeting & Director Nominations 29 Sep 2021 9:46AM $0.150 $0.009 fallen by 94%
$3 Change of Director's Interest Notice 13 Sep 2021 3:04PM $0.155 $0.009 fallen by 94.19%
$3 Notification regarding unquoted securities - ANR 9 Sep 2021 8:27AM $0.165 $0.009 fallen by 94.55%
$3 Meet the CEO Investor Webinar 7 Sep 2021 10:44AM $0.160 $0.009 fallen by 94.38%
$3 Investor Presentation 6 Sep 2021 9:36AM $0.150 $0.009 fallen by 94%
$3 Application for quotation of securities - ANR 26 Aug 2021 8:19AM $0.150 $0.009 fallen by 94%
$3 Appendix 4E & Financial Report 30 June 2021 24 Aug 2021 9:55AM $0.155 $0.009 fallen by 94.19%
$3 Anatara launches IBS-D Clinical Trial recruitment website 20 Aug 2021 8:13AM $0.150 $0.009 fallen by 94%
$3 Notification regarding unquoted securities - ANR 17 Aug 2021 8:21AM $0.160 $0.009 fallen by 94.38%
$3 Application for quotation of securities - ANR 17 Aug 2021 8:20AM $0.160 $0.009 fallen by 94.38%
$3 Successful Piglet Study 6 Aug 2021 9:02AM $0.160 $0.009 fallen by 94.38%
$3 Monthly Activities/Appendix 4C Cash Flow Report 28 Jul 2021 10:29AM $0.150 $0.009 fallen by 94%

251 - 275 of 539 results

Page 11 of 22

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.